Triazole alcohol antifungal compound with piperidine oxadiazole side chain and preparation method for compound and application of compound

A technology of oxadiazoles and oxadiazoles is applied in the field of triazole antifungal compounds and their preparation, and can solve the problems of large side effects, narrow antibacterial spectrum, easy generation of drug resistance and the like

Active Publication Date: 2016-03-09
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, as far as its clinical application is concerned, the existing antifungal drugs have problems such as large side effects, narrow antibacterial spectrum, and easy drug resistance, which are far from meeting the needs of clinical treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triazole alcohol antifungal compound with piperidine oxadiazole side chain and preparation method for compound and application of compound
  • Triazole alcohol antifungal compound with piperidine oxadiazole side chain and preparation method for compound and application of compound
  • Triazole alcohol antifungal compound with piperidine oxadiazole side chain and preparation method for compound and application of compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Example 1: Preparation of 1-[2-(2,4-difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole mesylate (Ⅱ)

[0101] Take 2-(1H-1,2,4-triazol-1-yl)-2',4'-difluoroacetophenone (Ⅰ) 29.8g (0.115mol), trimethyl iodine oxysulfide 25.3g ( 0.115mol), 1.6g of trimethylhexadecylammonium bromide, put into a 500ml three-necked flask, add 180ml of toluene and 225ml of 20% sodium hydroxide solution (w / w), heat at 60°C for 3 hours, and the reaction is completed Finally, separate the toluene layer, extract the water layer with ethyl acetate (100mlX2), combine the organic layers, wash with water until neutral, evaporate the solvent to dryness, add 120ml of ethyl acetate to the residual solution and dilute with 8.3g of formazan at 0°C. 2ml of ethyl acetate of sulfonic acid precipitated a pale yellow solid, which was filtered and recrystallized from methanol to obtain 21.71g of compound IV with a yield of 56.7% and a melting point of 128-129°C.

Embodiment 2

[0102] Embodiment 2: Preparation of N-Boc-4-hydrazinecarbonylpiperidine (III)

[0103] 2 g (7.77 mmol) of methyl N-tert-butoxycarbonyl-4-piperidinecarboxylate was dissolved in a (1:1) mixed solvent (30 mL) of hydrazine hydrate and ethanol, and stirred overnight at room temperature. Ethanol was concentrated to dryness, added to water (50 mL), dried with dichloromethane (50 mL×3), anhydrous sodium sulfate, filtered, and concentrated to obtain 1.8 g of white solid with a yield of 95%.

Embodiment 3

[0104] Embodiment 3: Preparation of N-Boc-4-hydrazide carbonyl piperidine compound (IV class compound)

[0105] Take 0.2g (0.82mmol) of N-Boc-4-hydrazinecarbonylpiperidine, 0.12g (1.23mmol) of triethylamine and dissolve it in dichloromethane (20mL), and slowly add 0.22g (1.23mmol) of nicotinyl chloride under ice bath ), and stirred at room temperature for 2 hours. Add dichloromethane (30mL) to dilute, wash with saturated brine (20mL×3), dry over anhydrous sodium sulfate, filter, concentrate, and obtain crude product by silica gel column chromatography (ethyl acetate:methanol=50:1-30: 1), 0.2 g of white solid was obtained, and the yield was 70%.

[0106] Other IV compounds are prepared by using III as a raw material, reacting with different aryl formyl chlorides as raw materials, and repeating the steps in Example 3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the medical technical field and provides 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-(piperidine oxadiazole side chain substituted)-2-propanol compounds in one category. The compound comprises cis-trans-isomers thereof and any mixtures in the forms or pharmaceutical salts thereof. The chemical structural formula of the compound is represented by a formula (I). The invention further provides a preparation method for the compound and an application of the compound in preparing antifungal drugs. From an antifungal experiment, the compound provided by the invention has a very strong antifungal effect on various superficial fungi and deep fungi. Compared with existing clinically applied antifungal drugs such as fluconazole, the compound has the advantages of being efficient, low in toxicity and wide in antifungal spectrum, has relatively good activity on fluconazole drug-resistant bacteria and can be used for preparing antifungal drugs. The formula is shown in the description.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a class of triazole alcohol antifungal compounds with piperidine oxadiazole side chains, a preparation method and application thereof, and an application in medicine. Background technique [0002] In recent years, with the extensive application of broad-spectrum antibiotics, antineoplastic drugs, and immunosuppressants, the widespread implementation of radiotherapy and organ transplantation, the widespread development of catheters and intubations, and the rapid increase in immunocompromised patients, especially AIDS patients, have resulted in Fungal infections, especially deep fungal infections, have risen sharply, and deep fungal infections have become the main cause of death from major diseases such as AIDS and tumors. Existing antifungal drugs mainly include amphotericin B that acts on fungal cell membrane lipids, nitrogen azoles that act on lanosterol 14-demethylase (flucona...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D413/14A61P31/10
CPCC07D211/62C07D405/06C07D413/04C07D413/14
Inventor 张万年盛春泉贺潇蒙王胜正董国强缪震元姚建忠刘娜
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products